Schedule 13D ownership disclosure

aTYR PHARMA INC

Security class unavailable · CUSIP: 002120103

Event date: 2015-05-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,866,126
Percent of class
8.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-15-031605
Form type
SC 13D
Filer
Sofinnova Venture Partners IX, L.P.
CIK
CIK 1612133
Filed
May 15, 2015
Reporting period
May 06, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub